Becker S, Feinberg J
UCSF School of Medicine, San Francisco, California, USA.
AIDS Clin Care. 2003 Sep;15(9):81.
In the first formally presented data on once-daily tenofovir + 3TC + abacavir, the regimen is shown to be suboptimal. Problem is, clinicians have already been using it.